Clinical Trial

Transcutaneous Electrical Acustimulation (TEA) for the Treatment of Non-Erosive Gastroesophageal Reflux Disease (NERD)

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This multicenter study aims to evaluate whether Transcutaneous Electrical Acustimulation (TEA) is effective in treating Non-Erosive Gastroesophageal Reflux Disease (NERD). NERD is a common condition where patients experience symptoms like heartburn and regurgitation, but no visible damage can be seen in the esophagus during an endoscopy. TEA is a non-invasive treatment that uses a small device to deliver mild electrical stimulation through the skin on specific acupoints. This study will compare the effects of real TEA treatment with a sham (inactive) control. Participants will be randomly assigned to one of two groups: active TEA treatment or sham stimulation. Neither the participants nor the researchers evaluating the outcomes will know which treatment is being given. The main outcome is the improvement of reflux symptoms after 4 weeks of treatment. The results of this study may provide a new non-drug option for patients suffering from NERD.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-01.
Trial Details
NCT Number NCT07572708
Lead Sponsor Ningbo Medical Center Lihuili Hospital
Conditions Non-erosive Reflux Disease (NERD)
Enrollment 204 participants
Start Date 2026-05-01
Primary Completion 2028-03-15 (estimated)
Study Completion 2028-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-15